We investigated the impact of chronic obstructive pulmonary disease (COPD) on in-hospital outcomes of patients undergoing conventional total aortic arch replacement (TAR), based on the Japan Adult Cardiovascular Surgery Database.
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) has been recognized as a significant risk factor for cardiovascular surgery [1, 2] . Postoperative respiratory failure is also a problematic issue in the elderly [3] . In thoracic endovascular aortic repair (TEVAR), preoperative risk evaluation and patient selection for conventional open surgical repair of thoracic aortic disease also have great significance for prognosis. For aortic arch aneurysm, the therapeutic strategy is shifting to endovascular managements in high-risk patient groups. However, information concerning the impact of obstructive lung disease on outcomes after aortic arch surgery has been derived from only single-centre retrospective studies [4, 5] . We conducted a retrospective multicentre survey to investigate the impact of the COPD on early outcomes in total arch replacement (TAR) using a nationwide, single-race population database, the Japan Adult Cardiovascular Surgery Database (JACVSD), which contains clinical data from almost all Japanese centres (http://www.jacvsd.umin.jp/). This study included patients who underwent elective TAR with reconstruction of the 3 brachiocephalic vessels via median sternotomy using antegrade cerebral perfusion or deep hypothermic circulatory arrest with retrograde cerebral perfusion. We analysed the influence of severity of preoperative obstructive pulmonary disease on surgical outcomes in patients who underwent elective TAR.
METHODS

Study population
Established in 2000, the JACVSD captures clinical information using a web-based data collection system that includes over 250 variables that are nearly identical to those in the Society for Thoracic Surgeons National Database. The system currently captures clinical information from 565 institutions, which include nearly all those performing cardiovascular surgery in Japan [6, 7] . A total of 12 590 patients electively underwent conventional TAR between January 2008 and December 2013 in Japan. Aortic dissection, aortic rupture, and other emergent surgeries were not included in this patient cohort.
In the JACVSD (http://www.jacvsd.umin.jp/), COPD is known as chronic pulmonary disease. It is defined as the presence of airflow obstruction confirmed by spirometry using the ratio of forced expiratory volume of air in 1 s (FEV 1 ) to forced vital capacity (FVC) in addition to bronchodilator or steroid use, or the presence of respiratory failure. Patients were divided into 4 categories according to the definition of chronic pulmonary disease: 10 040 (79.7%) with normal respiratory function and FEV 1 /FVC ratio of 76% or greater were classified as the control group; 1 890 patients (15.0%) with FEV 1 /FVC ratio 60-75% and/or use of bronchodilators were classified as mild airflow obstruction; 504 (4.0%) with FEV 1 /FVC ratio 50-59% and/or use of steroids were classified as moderate airflow obstruction; and 156 (1.2%) with FEV 1 / FVC ratio less than 50% and/or presence of respiratory failure were classified as severe airflow obstruction.
Study endpoints
We retrospectively analysed the data that were prospectively collected by the JACVSD. The primary end-points of this study were the operative outcomes including in-hospital mortality, 30-day mortality and major morbidity incidents. In-hospital mortality referred any death within the index hospitalization or within 30 days of the operation after discharge. Major morbidity was defined as any of the following 5 postoperative in-hospital complications: stroke (persistent neurologic dysfunction lasting more than 72 h), reoperation for any reason, need for mechanical ventilation for more than 24 h, renal failure with newly required dialysis, or deep sternal wound infection [8] . Using these outcome measures, results were evaluated after stratifying the patients by COPD severity according to the FEV. Furthermore, risk factors for these end-points were investigated with multi-variable analysis. All patients agreed to participate in the JACVSD preoperatively and additional informed consent was not required.
Patient demographics
The preoperative and operative variables according to the severity of airflow obstruction are shown in Tables 1 and 2 . Patients with poorer respiratory function were older and more were male. More severe airflow obstruction was also correlated with the prevalence of smoking history (P < 0.0001). History of cerebrovascular accident and incidence of chronic kidney and peripheral arterial disease were significantly associated with the severity of pulmonary disease (P < 0.0001, P < 0.0001, and P < 0.0001, respectively). Prevalence of chronic dissection (not atherosclerotic aneurysm) decreased significantly with progression of pulmonary disease (P < 0.0001).
Surgical approach
All patients underwent median sternotomy, using total cardiopulmonary bypass, and reconstruction of all arch vessels using 4-branched arch graft or island technique. Not all the details of surgical procedures were represented in the database, but nearly all patients had individual reconstruction of arch vessels using a 4-branched arch graft. Brain protection was performed with moderate hypothermia (average: 23.9 ± 3.4 C). The majority of patients underwent TAR using antegrade selective cerebral perfusion (83.2%). Hybrid procedures with open stent technique were excluded from the patient cohort.
Statistical analysis
All continuous variables are expressed as the mean ± standard deviation. To evaluate the effect of COPD severity on in-hospital outcomes, linear trends for clinical characteristics and results for variables across the four stages of COPD severity were assessed, using the Mantel-Haenszel test for categorical variables and the Jonckheere-Terpstra test for continuous variables. When P-value was less than 0.05, there was a significant increase among 4 ordinal groups representing the column order of COPD severity. To investigate the impact of COPD on outcomes of TAR, a multivariate logistic regression analysis was performed for in-hospital mortality. In the case of continuous variables, such as body-mass index, in which the relationship with outcome was not linear, we determined cut-off points. Moderate or greater COPD was used as a cut-off value in multivariate logistic regression analysis.
RESULTS
There was a tendency towards more frequent concurrent coronary artery bypass grafting in patients with more severe pulmonary disease (P = 0.021), and more transfusion was needed in these patients (P < 0.0001). However, in cases of more severe chronic pulmonary disease, concurrent valve surgery was less frequently performed (P < 0.0001) ( Table 2) .
Total incidence of in-hospital mortality and 30-day mortality was 5.7% and 3.2%, respectively. A significant increase in the severity of pulmonary disease was observed for both in-hospital mortality (5.2% in control, 7.0% in mild COPD, 9.3% in moderate COPD, and 9.0% in severe COPD) and 30-day mortality (3.0% in control, 3.9% in mild COPD, 4.2% in moderate COPD, and 5.1% in severe COPD) (P < 0.0001 and P = 0.005, respectively) ( Fig. 1A  and B) . The severity of pulmonary disease also affected the overall incidence of major complications, which increased step-wise according to the severity of airflow obstruction (27.2% in controls, 32.1% in mild COPD, 37.1% in moderate COPD and 42.3% in severe COPD; P < 0.0001) (Fig. 1C) . The overall incidence of postoperative stroke was 7.2% and the incidence also showed a significant increase according to COPD severity (6.7% in controls, 8.8% in mild COPD, 9.5% in moderate COPD and 13.5% in severe COPD; P < 0.0001) (Fig. 1D) .
Patients with more severe airflow obstruction also had a higher incidence of postoperative pneumonia (6.0% in controls, 11.0% in mild COPD, 12.3% in moderate COPD and 15.4% in severe COPD; P < 0.0001) ( Fig. 2A) and a greater need for prolonged ventilation (17.5% in controls, 22.0% in mild COPD, 26.6% in moderate COPD and 29.5% in severe COPD; P < 0.0001) (Fig. 2B) . Consequently, they tended to need longer time in intensive care (6.3 ± 0.12 days in control, 6.8 ± 0.25 days in mild COPD, 8.7 ± 0.65 days in moderate COPD, and 7.8 ± 1.1 days in severe COPD; P < 0.0001) (Fig. 2C) . The incidence of other postoperative morbidities according to the severity of pulmonary disease is shown in Table 3 . A risk model for in-hospital mortality was developed and a final logistic model with the odds ratio (OR) and 95% confidence intervals for the OR are presented in Table 4 . Variables confirmed as statistically significant risk factors are shown in Table 4 . The odds ratio of moderate/severe COPD for in-hospital mortality was 1.44 with confidence interval of 1.08-1.91 (P = 0.012).
DISCUSSION
We report nationwide and contemporary data on in-hospital outcomes for surgical TAR (12 590 procedures) in Japan between 2008 and 2013. During this period, a commercial available endovascular device began to be used for thoracic aortic lesions in Japan and a marked increase in the number of TEVAR procedures occurred contemporaneously with a relatively small increase in the number of surgical TAR procedures [9, 10] . The data reveal significant rising trends towards adverse outcomes, early mortality, major morbidity and composite events, according to the severity of chronic pulmonary disease in patients who underwent conventional TAR.
As the general population ages, the number of patients with aortic disease and prevalence of COPD are increasing. Since the introduction of TEVAR, patient selection for less-invasive interventions has become a matter of great concern, and COPD has drawn attention for preoperative risk stratification. The reported prevalence of COPD among patients with thoracic aortic disease ranged from 5.9 to 31.8%, because the definition of COPD varied among studies. In addition, its impact on adverse outcomes after TAR was rarely identified [11] [12] [13] . Previous studies have examined the effect of COPD on outcomes after cardiovascular surgery using data from single-centre studies with limited number of patients [4, 14] . A significant increase in in-hospital mortality was observed according to the severity of COPD. Similar results were also observed for other postoperative morbidities related to atherosclerotic pathology. Furthermore, moderate/severe COPD was recognised as a risk factor for in-hospital mortality. Although, information regarding the cause of mortality is not provided in the database, these patients were likely to have had risk factors related to atherosclerotic disease, as in the multivariate risk model. The causes of death were usually multifactorial. COPD directly and/or indirectly influenced such adverse events, because it is associated with prevalence of arteriosclerotic vascular disease [15] . The risk model showed that many atherosclerotic comorbidities have impact on early mortality. In addition to these risk factors, patients with severe COPD had more frequent pulmonary morbidities. It is not known whether and how much these pulmonary complications influenced the mortality rate, and whether these pulmonary complications are the direct result of severe COPD or secondary to other atherosclerotic complications such as stroke.
Lung injury secondary to the interruption of pulmonary circulation during circulatory arrest of the lower body causes pulmonary ischaemia [16, 17] . These pulmonary morbidities could aggravate other coexisting complications. In addition, postoperative stroke significantly increased according to COPD severity. Such patients are generally with postoperative stroke thought to have atherosclerotic comorbidity [18] . However, despite the relationship between COPD and atherosclerotic disease, the former could not be a direct cause of comorbidities, such as stroke and other complications related to atherosclerotic pathology. There is also a possibility that postoperative atrial fibrillation had an influence on the incidence of stroke, because patients with severe COPD also had more frequent postoperative atrial fibrillation. Less invasive alternatives to open surgery are needed for patients with medical comorbidities. A recent study on hybrid TEVAR versus open aortic arch repair indicated that hybrid TEVAR procedures have a benefit for patients with multiple comorbidities including age, atherosclerotic aortic lesions and COPD, especially for individuals with extensive pathology [19] . Open repair for extensive disease requires thoracotomy, which adversely affects the respiratory function [13] . The results of endovascular treatment for the descending thoracic aorta are equivalent to those for open surgical repair even in patients with a low comorbid burden [20] . Endovascular procedures are indicated for high-risk patients with extensive aortic lesions. In the present study, aortic arch lesions were at least accessible through median sternotomy. Furthermore, the number of patients with moderate/severe COPD was relatively small (5.2%), and only 1.2% had severe COPD. However, this small patient subgroup still warrants a prudent risk/benefit assessment, and is likely to benefit from less-invasive endovascular management.
LIMITATIONS
This study had some limitations because of the retrospective observational design. First, a web-based database was used to collect information from every institution in Japan. Consequently, input errors could have occurred. Second, insufficient clinical details, especially the cause of death, prevented further analysis of the influence of COPD on operative mortality and morbidity. Third, there is a possibility that chronic pulmonary disease did not always indicate COPD in the JACVSD. The hallmark of COPD is the presence of airflow obstruction that is most commonly assessed by spirometry and expressed by as the ratio of the FEV 1 to the predicted value, not merely by the FEV 1 /FVC ratio. Predicted FEV 1 from 60% to 70% is usually defined as comorbid COPD [2, 21] . Moreover, the estimation of COPD severity using only spirometry may be inaccurate because clinical symptoms are not considered [22] . Fourth, the small number of patients in Japan who underwent total debranching of the supra-aortic vessels prevented us from performing direct comparisons between 2 different therapeutic strategies. Furthermore, we could not extract detailed data regarding the heterogeneity of strategies for stentgraft procedures on aortic arch lesions from the JACVSD. However, the size and nature of the data set are useful as a comprehensive survey of trends focused on a specific patient background. Finally, our analysis was restricted to a single-race population, and may not be applicable to other populations.
CONCLUSIONS
We analysed all elective TAR procedures performed in Japan between 2008 and 2013. The severity of preoperative airflow obstruction had an increased influence on mortality and morbidity including stroke in patients who underwent conventional TAR. 
